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Objectives: Radiological imaging plays an important role in the evaluation of
pulmonary cystic ﬁbrosis (CF) for the detection of both disease progression
and parenchymal lesions. Tomosynthesis (digital tomography) has been recently
proposed for pulmonary CF because it has comparatively low radiation dose (0.08–
0.12mSv) and, compared to radiography, it is more sensitive to CF changes, showing
them in more details.
The purpose of this study is to design and validate a scoring system for tomosyntesis
in pulmonary cystic ﬁbrosis of adult patients, comparing with chest radiography,
computed tomography (gold standard) and functional parameter (FEV1).
Methods: To better investigate strengths and weaknesses of tomosynthesis, we
independently scored radiography, tomosynthesis and HRCT examinations of the
chest in a group of 20 adult CF patients (23 to 61 years, mean 39 years).
Also, we suggested a scoring system to evaluate the whole spectrum of mild
to severe pulmonary changes, with well-deﬁned scoring parameters, valid for all
radiological investigations.
The scoring form provided clear deﬁnitions for the severity and extend of ﬁve
well-recognised pathological changes: overinﬂation, bronchiectasis, bronchial wall
thickening, parenchymal lesions and mucus plugging.
Conclusion: We found that correlation between the tomosynthesis and HRCT was
high (square-weighted kappa = 0.99) and there was agreement in determining the
location and extent of all lesions. We conclude that tomosynthesis is a useful tool
in the regular follow-up of CF patients, allowing greater diagnostic accuracy than
radiography and lower radiation dose compared with HRCT.
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Aim: To longitudinally evaluate physical performance and quality of life in a cohort
of adult CF patients (non transplant candidates).
Methods: Physical performance and quality of life were measured at two time
points (at least six month apart) with pulmonary function (FEV1), six-minute walk
test (6MWT) the St George’s Respiratory Questionnaire (SGRQ) and CFQ-R (only
at second evaluation).
Results: 26 patients (13 females) with a mean age of 28±10 years, body mass
index (BMI) of 22±3 kg/m2, FEV1 2.4±1.4 litre (63±29%) and 6MWT 703±148
meter were investigated. Total score of SGRQ at ﬁrst evaluation was 22±14 (healthy
adults <6), with a symptom score of 44±21 (<9), activity score of 23±22 (<2) and
impact score of 14±13 (<6). Results of the CFQ-R are comparable to published
date from the literature. Mean change in BMI, FEV1, FEV1%predicted and 6MWT
at second evaluation (8.3±4.0 months after ﬁrst evaluation) was 0.18±0.69 kg/m2,
0.02±0.30 litre, 0.08±7.82% and 9.7±98.3 meter, respectively. Mean change in
SGQR was 4.9±14.0, 3.6±7.2, −2.5±16, 3.0±8.3 for activity, impact, symptoms
and total score, respectively. 6MWT and FEV1 are strongly correlated with the
SGQR but no correlation of change in SGQR and delta 6MWT and FEV1 over
time was found.
Conclusion: The speciﬁc respiratory questionnaire (SGRQ) showed an impairment
of respiration related quality of life compared to healthy adults. SGQR was strongly
correlated with FEV1 and 6MWT. Due to the small changes in physical performance
over the whole observation time no signiﬁcant correlation of change in FEV1 and
6MWT to SGQR was found.
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Background: Exercise tolerance is reduced in adult patients with cystic ﬁbrosis
(CF). The aim of this retrospective analysis was to determine the mechanisms
responsible for exercise intolerance.
Methods: Cardiopulmonary exercise testing (CPET) with blood gas analysis at peak
exercise was performed in 102 patients aged 28±11 years. VO2 peak was measured
and correlated with clinical, biological and functional parameters.
Results: VO2 peak was decreased (<84%) in 85% of patients and was correlated
with BMI, CRP, FEV1, FVC, RV and DLCO. Among the CPET variables, VO2
peak was correlated with VE/VO2 at ventilatory threshold (VT), peak VD/VT,
PaO2, PaCO2, P(A-a)O2 and ventilatory reserve. In multivariate analysis, FEV1
was the major signiﬁcant predictor of VO2 peak impairment, accounting for 48%
of VO2 peak alteration. Reduced or absent ventilatory reserve and excessive
hyperventilation (VE/VO2 VT) accounted for 10% and 8% of VO2 alteration,
respectively. VD/VT and P(A-a)O2 peak each accounted for 1% of the change
in VO2 peak value.
Conclusion: Exercise limitation in adult patients with CF is largely dependent
on FEV1 but is also affected by nutritional and inﬂammatory status and by the
ventilatory response to exercise.
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Objectives: The aim of this study was to prospectively evaluate the CFQ-R and
SGRQ and to look on the impact of clinical data on both questionnaires.
Methods: Clinical data including pulmonary function test (PFT), the rates of CF-
exacerbation in the last year (IER), CF related diabetes (CFDM) and positivity for
pseudomonas aeruginosa (PA) were collected. Spearman correlation was performed
for these clinical data with CFQ-R and SGRQ. Univariate and multivariate analysis
for CFQ-R and SGRQ were performed with the following factors: gender, age,
BMI, CFDM, FEV1%predicted, patients with and without PA and IER.
Results: 38 patients (16 females) are evaluated with a mean age of 29 y (95%CI
25−32), body-mass index (BMI) of 22.0 kg/m2 (22.9–23.2), FEV1%pred of 64%
(55−74). FEV1%predicted was strongly correlated (p0.0001) with SGRQ activity
and total score but only moderately (p< 0.005) with CFQ-R physical functioning
and SGRQ symptom score. IER was strongly correlated with CFQ-R role, SGRQ
activity and total score and moderately with CFQ-R physical functioning, treatment
burden and health perception and SGRQ impact score. FEV1%predicted, IER,
CFQ-R and SGRQ are signiﬁcantly inﬂuenced by PA. In the multivariate analysis
FEV1%predicted and IER had a signiﬁcant inﬂuence on SGQR.
Conclusions: In adult CF patients CFQ-R is only moderately correlated with PFT
and CF-exacerbation rate in the last year. In contrast, the SGRQ showed a better
correlation with PFT and IER. SGRQ is a useful tool to measure health related
quality of life in CF patients.
